下调和上调
泛素
医学
信号转导
转基因小鼠
肺
体内
转基因
细胞生物学
内分泌学
癌症研究
内科学
化学
生物
生物化学
基因
生物技术
作者
Étienne-Marie Jutant,Mustapha Kamel Chelgham,Mina Ottaviani,Raphaël Thuillet,Benjamin Le Vely,Marc Humbert,Christophe Guignabert,Ly Tu,Alice Huertas
标识
DOI:10.1016/j.healun.2023.09.003
摘要
Background
Leptin receptor (ObR-b) is overexpressed in pulmonary artery smooth muscle cells (PA-SMCs) from patients with pulmonary arterial hypertension (PAH) and is implicated in both mechanisms that contribute to pulmonary vascular remodeling: hyperproliferation and inflammation. Our aim was to investigate the role of ubiquitin-specific peptidase 8 (USP8) in ObR-b overexpression in PAH. Methods
We performed in situ and in vitro experiments in human lung specimens and isolated PA-SMCs combined with 2 different in vivo models in rodents and we generated a mouse with an inducible USP8 deletion specifically in smooth muscles. Results
Our results showed an upregulation of USP8 in the smooth muscle layer of distal pulmonary arteries from patients with PAH, and upregulation of USP8 expression in PAH PA-SMCs, compared to controls. USP8 inhibition in PAH PA-SMCs significantly blocked both ObR-b protein expression level at the cell surface as well as ObR-b-dependant intracellular signaling pathway as shown by a significant decrease in pSTAT3 expression. USP8 was required for ObR-b activation in PA-SMCs and its inhibition prevented Ob-mediated cell proliferation through STAT3 pathway. USP8 inhibition by the chemical inhibitor DUBs-IN-2 protected against the development of experimental PH in the 2 established experimental models of PH. Targeting USP8 specifically in smooth muscle cells in a transgenic mouse model also protected against the development of experimental PH. Conclusions
Our findings highlight the role of USP8 in ObR-b overexpression and pulmonary vascular remodeling in PAH.
科研通智能强力驱动
Strongly Powered by AbleSci AI